Onset of rheumatoid arthritis in the elderly age - difficulties of diagnostic and treatment: a clinical case
- Authors: Filimonova O.G.1, Chicherina E.N1, Betekhtina S.N2
-
Affiliations:
- Kirov State Medical University
- Branch Clinical Hospital at Kirov station of the JSC Russian Railways
- Issue: No 14 (2018)
- Pages: 67-71
- Section: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/296506
- DOI: https://doi.org/10.18565/pharmateca.2018.14.67-71
- ID: 296506
Cite item
Open Access
Access granted
Abstract
Background. Rheumatoid arthritis (RA) is a chronic autoimmune disease, manifested by progressive destruction of the joints, systemic inflammation of the internal organs and a wide range of comorbid diseases associated with chronic inflammation, and often with side drug effects. Description of the clinical case. The article presents a clinical case of successful diagnosis and treatment of RA in an elderly patient debuted with recurrent synovitis of the knee joints. The presence of serious comorbid pathology, the occurrence of side effects against the first-line background therapy created certain difficulties in the management of the patient. Conclusion. Early diagnosis and treatment of RA in elderly patients is significantly difficult even with the availability of modern research methods for a rheumatologist. The presence of comorbid pathology may limit the use of certain pharmaceuticals and cause side effects. Not only the presence of comorbidities, but also the age, features of the course of RA should be taken into account in selection of background therapy.
Full Text
About the authors
Oksana G. Filimonova
Kirov State Medical University
Email: fioks24@mail.ru
PhD, Associate Professor at the Department of Internal Diseases
E. N Chicherina
Kirov State Medical University
S. N Betekhtina
Branch Clinical Hospital at Kirov station of the JSC Russian Railways
References
- Smolen J.S., Aletaha D., Mcinnes I.B. Rheumatoid arthritis. Lancet. 2016;388(10055):2023-38. Doi: https://doLorg/10.W16/S0140-6736(16) 30173-8
- Mcinnes I.B., Schett G. Pathogenetic insights from the treatment of rheumatoid arthritis. Lancet. 2017;389:2328-37. Doi: https://doi.org/10.1016/ S0140-6736(17)31472-1
- Catrina A.I., Svensson C.I., Malmstrm V., et al. Mechanisms leading from systemic autoimmunity to joint-specific disease in rheumatoid arthritis. Nat. Rev. immunol. 2017;13(2):79-86. Doi: https://doi. org/10.1038/nrrheum.2016.200
- Mankia K., Emery P. Preclinical rheumatoid arthritis. Progress toward prevention. Arthr. Rheum. 2016;68:779-88. doi: 10.1002/art.39603.
- Насонов Е.Л. Проблемы иммунопатологии ревматоидного артрита: эволюция болезни. Научно-практическая ревматология. 2017;55(3):277-94.
- Калюта Т.Ю., Артанова Е.Л., Кац Я.А. Дебют ревматоидного артрита в старческом возрасте. Фундаментальные исследования. 2012;5-1:36-43.
- Насонов Е.Л. Ревматоидный артрит. В. кн.: Российские клинические рекомендации. М., 2017. С. 17-57.
- Леушина Е.А., Кошкина Е.А., Салтыкова Е.А. Трудности диагностики и фармакотерапия ревматоидного артрита: клинический случай. Фарматека. 2017;3-17:22-7.
- Сатыбалдыев А.М. Ревматоидный артрит у пожилых. Consilium Medicum. 2007;12:85-92.
- Никитина Н.М., Афанасьев И.А., Романова Т.А., Ребров А.П. Особенности коморбидности у больных ревматоидным артритом в разные годы наблюдения. Современная ревматология. 2015;1:39-
- Boers M., Dijkmans B., Gabriel S., et al. Making an impact on mortality in rheumatoid arthritis. Targeting cardiovascular comotbidity. Arthr. Rheum. 2004;50(6):1734-39. doi: 10.1002/art.20306.
Supplementary files
